Life-extension drugs

Life-extension drugs

Cycloastragenol (TA-65 active substance) prescribing information

 

Rejuvenation Res. 2011 Feb;14(1):45-56
Harley CB, Liu W, Blasco M, Vera E, Andrews WH, Briggs LA, Raffaele JM.
Geron Corporation, Menlo Park, California, USA.

A natural product telomerase activator as part of a health maintenance program.

Most human cells lack sufficient telomerase to maintain telomeres, hence these genetic elements shorten with time and stress, contributing to aging and disease. In January, 2007, a commercial health maintenance program, PattonProtocol-1, was launched that included a natural product-derived telomerase activator (TA-65, 10-50 mg daily), a comprehensive dietary supplement pack, and physician counseling/laboratory tests at baseline and every 3-6 months thereafter. We report here analysis of the first year of data focusing on the immune system. Low nanomolar levels of TA-65 moderately activated telomerase in human keratinocytes, fibroblasts, and immune cells in culture; similar plasma levels of TA-65 were achieved in pilot human pharmacokinetic studies with single 10- to 50-mg doses. The most striking in vivo effects were declines in the percent senescent cytotoxic (CD8(+)/CD28(-)) T cells (1.5, 4.4, 8.6, and 7.5% at 3, 6, 9, and 12 months, respectively; p = not significant [N.S.], 0.018, 0.0024, 0.0062) and natural killer cells at 6 and 12 months (p = 0.028 and 0.00013, respectively). Most of these decreases were seen in cytomegalovirus (CMV) seropositive subjects. In a subset of subjects, the distribution of telomere lengths in leukocytes at baseline and 12 months was measured. Although mean telomere length did not increase, there was a significant reduction in the percent short (<4 kbp) telomeres (p = 0.037). No adverse events were attributed to PattonProtocol-1. We conclude that the protocol lengthens critically short telomeres and remodels the relative proportions of circulating leukocytes of CMV(+) subjects toward the more "youthful" profile of CMV(-) subjects. Controlled randomized trials are planned to assess TA-65-specific effects in humans.


Aging Cell. 2011 Aug;10(4):604-21
de Jesus BB, Schneeberger K, Vera E, Tejera A, Harley CB, Blasco MA.
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Melchor Fern?ndez Almagro 3, Madrid, Spain.

The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.

Here, we show that a small-molecule activator of telomerase (TA-65) purified from the root of Astragalus membranaceus is capable of increasing average telomere length and decreasing the percentage of critically short telomeres and of DNA damage in haploinsufficient mouse embryonic fibroblasts (MEFs) that harbor critically short telomeres and a single copy of the telomerase RNA Terc gene (G3 Terc(+/-) MEFs). Importantly, TA-65 does not cause telomere elongation or rescue DNA damage in similarly treated telomerase-deficient G3 Terc(-/-) littermate MEFs. These results indicate that TA-65 treatment results in telomerase-dependent elongation of short telomeres and rescue of associated DNA damage, thus demonstrating that TA-65 mechanism of action is through the telomerase pathway. In addition, we demonstrate that TA-65 is capable of increasing mouse telomerase reverse transcriptase levels in some mouse tissues and elongating critically short telomeres when supplemented as part of a standard diet in mice. Finally, TA-65 dietary supplementation in female mice leads to an improvement of certain health-span indicators including glucose tolerance, osteoporosis and skin fitness, without significantly increasing global cancer incidence.


Cycloastragenol (TA-65 active substance) review article...

 

My BasketMy Basket

Geroprotector
Cycloastragenol (TA-65 active substance)
Cycloastragenol (TA-65 active substance) prescribing information


Buy here


Cycloastragenol (TA-65 active substance) review article


Newsletter subscription


Product search

Product list

- ASTRAGALOSIDE IV
- ATORVASTATIN
- AVEMAR IMMUNE BOOSTER
- B-VITAMIN COMPLEX
- B-VITAMIN COMPLEX FORTE
- B6 VITAMIN
- CAFFEINE COMPLEX
- CALCITRIO
- CAVINTON
- CENTROPHENOXINE
- CIALIS
- COAXIL
- COENZYME Q10
- CYCLOASTRAGENOL (TA-65 ACTIVE SUBSTANCE)
- D3 VITAMIN
- DEPRENYL
- DOXYCYCLINE
- E VITAMIN
- EGCG
- ELDEPRYL
- FAT BURNER
- FISH OIL
- FOLIC ACID
- HYDROXYTYROSOL
- IMUNOVIR
- INULIN
- IODIDE (KI)
- IODINE WATER
- ISOPRINOSINE
- JUMEX
- K-2 VITAMIN
- K-2, D-3, K-1 VITAMINS
- LEUZEA ROOT
- LIFE EXTENDING KIT
- LIPITOR
- LIPOIC ACID
- MACA VIBE
- MELATONIN
- METFORMIN
- MILGAMMA
- MUMIJO (MUMIO)
- N-ACETYLCYSTEINE (NAC)
- NADH
- NOOTROPIL
- PANTOCRIN
- PIRACETAM
- PQQ
- PUMPKINSEED OIL
- RAPAMYCIN
- RED WINE HIGH IN RESVERATROL
- RESVERATROL
- RHODIOLA ROOT
- RHODIOLA TABLETS
- ROSUVASTATIN
- RUTIN
- SCHISANDRA
- SEA-BUCKTHORN
- SELEGILIN
- SELENIUM
- STABLON
- THIOGAMMA (LIPOIC ACID)
- VALERIAN
- VINPOCETINE
- VINPOTROPILE
- XENICAL
- ZINC (ZN)

You are located on a secure website.
Customer data is for our internal use only and will be treated as confidential.

eXTReMe Tracker